Literature DB >> 361901

In vitro studies of amphotericin B in combination with the imidazole antifungal compounds clotrimazole and miconazole.

R F Cosgrove, A E Beezer, R J Miles.   

Abstract

The clinically important polyene antibiotic amphotericin B, in combination with two antifungal imidazole compounds, clotrimazole and miconazole, was studied in vitro. With use of results of cytoplasmic leakage, metabolic heat output, and minimal inhibitory concentration studies, a definite antagonistic response was demonstrated. It is suggested that, if combined antifungal drug therapy is clinically indicated, the drug combination be tested against the isolate by the simple technique of measuring cytoplasmic leakage or by the more elaborate method of flow microcalorimetry.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 361901

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

Review 1.  Combination antifungal therapy.

Authors:  Melissa D Johnson; Conan MacDougall; Luis Ostrosky-Zeichner; John R Perfect; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

2.  The place of elective vitrectomy in the management of patients with Candida endophthalmitis.

Authors:  T Barrie
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

Review 3.  Use of amphotericin B with azole antifungal drugs: what are we doing?

Authors:  A M Sugar
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

4.  Effect of ketoconazole and amphotericin B on encapsulated and non-encapsulated strains of Cryptococcus neoformans.

Authors:  D Smith; H W McFadden; N G Miller
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

Review 5.  Clinical pharmacokinetics of systemic antifungal drugs.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

6.  Antibiotic bioassay by flow microcalorimetry.

Authors:  A E Beezer; R J Miles; E J Shaw; L Vickerstaff
Journal:  Experientia       Date:  1980-09-15

Review 7.  Treatment of systemic fungal infections: recent progress and current problems.

Authors:  T J Walsh; A Pizzo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

8.  Effect of ketoconazole on the fungicidal action of amphotericin B in Candida albicans.

Authors:  I J Sud; D S Feingold
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

9.  Entry of ketoconazole into Candida albicans.

Authors:  P Boiron; E Drouhet; B Dupont; L Improvisi
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

10.  Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum.

Authors:  E Martin; F Maier; S Bhakdi
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.